Cargando…
Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240082/ https://www.ncbi.nlm.nih.gov/pubmed/35764610 http://dx.doi.org/10.1038/s41392-022-01023-w |
| _version_ | 1784737462497574912 |
|---|---|
| author | Li, Xiaohe Wu, Liwen Qu, Youzhi Cao, Mengli Feng, Jiaqi Huang, Hua Liu, Yi Lu, Hongzhou Liu, Quanying Liu, Yingxia |
| author_facet | Li, Xiaohe Wu, Liwen Qu, Youzhi Cao, Mengli Feng, Jiaqi Huang, Hua Liu, Yi Lu, Hongzhou Liu, Quanying Liu, Yingxia |
| author_sort | Li, Xiaohe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9240082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92400822022-06-30 Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children Li, Xiaohe Wu, Liwen Qu, Youzhi Cao, Mengli Feng, Jiaqi Huang, Hua Liu, Yi Lu, Hongzhou Liu, Quanying Liu, Yingxia Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-06-28 /pmc/articles/PMC9240082/ /pubmed/35764610 http://dx.doi.org/10.1038/s41392-022-01023-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Li, Xiaohe Wu, Liwen Qu, Youzhi Cao, Mengli Feng, Jiaqi Huang, Hua Liu, Yi Lu, Hongzhou Liu, Quanying Liu, Yingxia Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title | Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title_full | Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title_fullStr | Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title_full_unstemmed | Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title_short | Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children |
| title_sort | clinical characteristics and vaccine effectiveness against sars-cov-2 omicron subvariant ba.2 in the children |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240082/ https://www.ncbi.nlm.nih.gov/pubmed/35764610 http://dx.doi.org/10.1038/s41392-022-01023-w |
| work_keys_str_mv | AT lixiaohe clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT wuliwen clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT quyouzhi clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT caomengli clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT fengjiaqi clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT huanghua clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT liuyi clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT luhongzhou clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT liuquanying clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren AT liuyingxia clinicalcharacteristicsandvaccineeffectivenessagainstsarscov2omicronsubvariantba2inthechildren |